Arcus Revenue and Competitors

Claim your profile



Total Funding



Estimated Revenue & Valuation

  • Arcus's estimated annual revenue is currently $16M per year.(i)
  • Arcus's estimated revenue per employee is $130,000

Employee Data

  • Arcus has 123 Employees.(i)
  • Arcus grew their employee count by 24% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation

Arcus is the best protocol for becoming the hub of your consumers financial health. Over 40 banks and fintech companies leverage our technology to facilitate their consumers' bill payments and management. Arcus launched in Y-Combinator in 2013 and its investors include Kapor Capital, Winklevoss Capital, Maverick Capital, Banco Itau and others.

keywords:Ventures for Good, Developer APIs, Mobile Payments, Emerging Markets


Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Arcus News

2020-11-02 - Arcus Raises Funding from Citi Ventures

Arcus, a New York City-based Fintech-as-a-Service (FaaS) platform, received an investment of undisclosed amount from Citi Ventures. This investment will help facilitate the company’s growth in Mexico and to expand its biller network and facilitate consumer payments in the region. Led by Inigo ...

2020-11-02 - Fintech-As-A-Service Platform Arcus Secures Funding From Citi Ventures For Expansion & Partnerships in Latin America

Arcus, a Fintech-as-a-Service (FaaS) platform, announced on Monday it scored an investment from Citi Ventures for expansion and partnerships in Latin America. Arcus claims that this investment marks the first investment by Citi Ventures in a fintech company in Mexico. Founded in 2013, Arcus pro ...

09/03/2019 - Arcus Biosciences to Present at Upcoming Investor Conferences

HAYWARD, Calif--(BUSINESS WIRE)--. Arcus Biosciences, Inc. (RCUS), a clinical-stage biopharmaceutical company focused on creating ...

09/08/2019 - Infinity Pharmaceuticals Announces the Initiation of Two ...

Phase 1/1b Study with Arcus Biosciences to Evaluate Triple Combination Therapy with IPI-549 in Advanced Triple Negative Breast Cancer -- ...

09/03/2019 - Is Arcus Biosciences, Inc. ($RCUS) Set To Blow Up? (2019-09-06)

On its latest session, Arcus Biosciences, Inc. ($RCUS) opened at 7.57, reaching a high of 7.91 and a low of 7.45 before closing at a price of 7.8.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding